Stay updated with breaking news from Christopher Morabito. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report)’s stock price dropped 2.9% during trading on Tuesday after HC Wainwright lowered their price target on the stock from $18.00 to $16.00. HC Wainwright currently has a buy rating on the stock. Astria Therapeutics traded as low as $9.51 and last traded at $9.52. Approximately 312,375 shares […]
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report)’s stock price was down 2.9% during mid-day trading on Tuesday after HC Wainwright lowered their price target on the stock from $18.00 to $16.00. HC Wainwright currently has a buy rating on the stock. Astria Therapeutics traded as low as $9.51 and last traded at $9.52. Approximately […]
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report)’s stock price dropped 2.9% during trading on Tuesday after HC Wainwright lowered their price target on the stock from $18.00 to $16.00. HC Wainwright currently has a buy rating on the stock. Astria Therapeutics traded as low as $9.51 and last traded at $9.52. Approximately 312,375 shares […]
Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report)’s stock price was up 2.9% during mid-day trading on Tuesday . The stock traded as high as $11.26 and last traded at $11.21. Approximately 110,589 shares traded hands during trading, a decline of 89% from the average daily volume of 980,668 shares. The stock had previously closed […]
Astria Therapeutics (NASDAQ:ATXS – Free Report) had its price objective increased by Jefferies Financial Group from $22.00 to $27.00 in a research report sent to investors on Monday, Benzinga reports. Jefferies Financial Group currently has a buy rating on the biotechnology company’s stock. Several other research firms also recently commented on ATXS. Wedbush reaffirmed an […]